Send to a Friend Font Size: Increase Decrease

ALNY and RO Related Headlines

Aug 30, 2025 10:30AM Genentech and Alnylam Advance Zilebesiran Into Global Phase III Cardiovascular Outcomes Trial for People With Uncontrolled Hypertension

ALNY and RO Related Press Releases

Aug 30, 2025 10:30AM Genentech and Alnylam Advance Zilebesiran Into Global Phase III Cardiovascular Outcomes Trial for People With Uncontrolled Hypertension

ALNY and RO Related SEC Filings